<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03126344</url>
  </required_header>
  <id_info>
    <org_study_id>suny2</org_study_id>
    <nct_id>NCT03126344</nct_id>
  </id_info>
  <brief_title>Nasal Intubation Using King Vision Video Laryngoscopy</brief_title>
  <official_title>Comparison King Vision Video Laryngoscopy 、McGrath MAC Video Laryngoscopy With Macintosh Laryngoscopy for Nasal Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 9th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 9th People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to determine the comparison between the King Vision video
      laryngoscope 、 McGrath MAC video laryngoscope and Macintosh laryngoscope for nasotracheal
      intubation.Patients were divided into 3 groups of 30 patients each.Patients of King Vision
      group [n=30]、 McGrath MAC group [n=30] and Macintosh group[n=30]were intubated using
      respective devices.This study is the first to search the use of King Vision video
      laryngoscope for nasotracheal intubation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to intubation</measure>
    <time_frame>0 min after nasal intubation</time_frame>
    <description>from taking of the intubation device to successful intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ease of intubation</measure>
    <time_frame>5 min after nasal intubation</time_frame>
    <description>VAS scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of complications</measure>
    <time_frame>24h after surgery</time_frame>
    <description>sore throat, hoarseness, etc</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Nasal Intubation</condition>
  <arm_group>
    <arm_group_label>King Vision video laryngoscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>McGrath MAC video laryngoscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Macintosh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>King Vision video laryngoscope</intervention_name>
    <description>nasal intubation using King Vision video laryngoscope Device after general anesthesia induction</description>
    <arm_group_label>King Vision video laryngoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>McGrath MAC video laryngoscope</intervention_name>
    <description>nasal intubation using McGrath MAC video laryngoscope Device after general anesthesia induction</description>
    <arm_group_label>McGrath MAC video laryngoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Macintosh laryngoscope</intervention_name>
    <description>nasal intubation using Macintosh laryngoscope Device after general anesthesia induction</description>
    <arm_group_label>Macintosh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status 1-2

          -  general anesthesia with nasotracheal intubation

          -  anticipated difficult airway

        Exclusion Criteria:

          -  contraindications to nasal intubation

          -  Patients with a history of anti-hypertensive drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yu Sun, MD,PhD</last_name>
    <phone>0086-136-1189-5542</phone>
    <email>dr_sunyu@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haozhen Zhu, MM</last_name>
    <phone>0086-189-1889-0657</phone>
    <email>zhuhaozhen921@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital,Affililated to Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Sun, MD,PhD</last_name>
      <phone>0086 13611895542</phone>
      <email>dr_sunyu@163.com</email>
    </contact>
    <investigator>
      <last_name>Haozhen Zhu, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>May 20, 2017</last_update_submitted>
  <last_update_submitted_qc>May 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 9th People's Hospital</investigator_affiliation>
    <investigator_full_name>Sun Yu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>King Vision</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

